Research Frontiers (REFR) Peer Comparison
$0.46
As on 28-Aug-2026 13:30EDT
Market cap
$16 Mln
Revenue (TTM)
$1 Mln
P/E Ratio
--
P/B Ratio
14
Div. Yield
0 %
| Research Frontiers (REFR) | Warner Music Group Corp. Class A (WMG) | Madison Square Garden Sports Corp. Class A (New) (MSGS) | Pharmhouse Corp (PHSE) | LiveOne (LVO) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
16 | 14,192 | 9,780 | 67 | 54 |
Revenue ($ Mln) |
1 | 7,304 | 1,154 | 7 | 77 |
Net Profit ($ Mln) |
-2.25 | 672.00 | 7.76 | -12.93 | -19.97 |
Net Margin (%) |
-343.85 | 9.20 | 0.67 | -195.91 | -25.83 |
RoE (%) |
-218.76 | 86.28 | -2.85 | -26.19 | -- |
Price to Earnings |
-- | 21.70 | 1,269.25 | -- | -- |
Price-To-Book |
13.97 | 16.60 | 1.57 | 1.28 | 27.53 |
Income Statement ($ Mln)
| Research Frontiers (REFR) | Warner Music Group Corp. Class A (WMG) | Madison Square Garden Sports Corp. Class A (New) (MSGS) | Pharmhouse Corp (PHSE) | LiveOne (LVO) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
0.65 | 7,304.00 | 1,153.82 | 6.60 | 77.29 |
|
Cost of Revenue
|
0.66 | 3,961.00 | 833.70 | 1.54 | 64.10 |
|
Gross Profit
|
0.93 | 3,075.00 | 280.88 | 2.35 | 27.22 |
|
Operating Expenses
|
2.84 | 2,298.00 | 291.25 | 17.25 | 28.31 |
|
Operating Profit (EBIT)
|
-2.28 | 1,045.00 | 28.87 | -12.19 | -15.12 |
|
Other Income
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
Profit before Tax
|
-2.25 | 873.00 | 17.98 | -12.61 | -20.45 |
|
Provision for Tax
|
0.00 | 208.00 | 10.22 | 0.00 | 0.02 |
|
Profit after Tax (Net Income)
|
-2.25 | 672.00 | 7.76 | -12.93 | -19.97 |
|
Minority Interest
|
0.00 | 7.00 | 0.00 | 0.00 | 0.02 |
|
Consolidated Profit
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Liabilities ($ Mln)
| Research Frontiers (REFR) | Warner Music Group Corp. Class A (WMG) | Madison Square Garden Sports Corp. Class A (New) (MSGS) | Pharmhouse Corp (PHSE) | LiveOne (LVO) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
1.12 | 854.00 | -263.30 | 46.40 | -13.68 |
|
Minority Interest
|
0.00 | 7.00 | 0.00 | 0.00 | 0.02 |
|
Non-Current Liabilities
|
0.94 | 5,198.00 | 1,158.51 | 0.17 | 19.67 |
|
Current Liabilities
|
0.41 | 4,443.00 | 642.44 | 7.25 | 34.10 |
|
Total Liabilities
|
2.25 | 9,829.00 | 1,580.77 | 60.35 | 40.52 |
Assets ($ Mln)
| Research Frontiers (REFR) | Warner Music Group Corp. Class A (WMG) | Madison Square Garden Sports Corp. Class A (New) (MSGS) | Pharmhouse Corp (PHSE) | LiveOne (LVO) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
1.02 | 7,467.00 | 1,214.36 | 50.01 | 26.96 |
|
Current Assets
|
1.46 | 3,260.00 | 323.29 | 3.81 | 21.77 |
|
Total Assets
|
2.25 | 9,829.00 | 1,580.77 | 60.35 | 40.52 |
|
Total Debt*
|
1.09 | 4,919.00 | 1,143.81 | 4.71 | 14.35 |
|
Net Current Assets
|
1.04 | -1,183.00 | 0.00 | 0.00 | 0.00 |
Cashflow ($ Mln)
| Research Frontiers (REFR) | Warner Music Group Corp. Class A (WMG) | Madison Square Garden Sports Corp. Class A (New) (MSGS) | Pharmhouse Corp (PHSE) | LiveOne (LVO) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-1.33 | 678.00 | 91.61 | -2.49 | 6.37 |
|
Cash Flow from Investing Activities
|
0.00 | -340.00 | -6.92 | 0.01 | -3.12 |
|
Cash from Financing Activities
|
0.00 | -497.00 | -26.41 | 1.46 | -6.24 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Research Frontiers (REFR) | Warner Music Group Corp. Class A (WMG) | Madison Square Garden Sports Corp. Class A (New) (MSGS) | Pharmhouse Corp (PHSE) | LiveOne (LVO) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
-68.18 | 7.14 | -2.58 | -32.70 | 407.56 |
|
ROE (%)
|
-218.76 | 86.28 | 8.19 | -26.19 | 173.58 |
|
ROA (%)
|
-70.97 | 4.63 | 0.39 | -44.52 | -26.03 |
|
EBIT Margin (%)
|
-345.32 | 14.09 | 3.39 | -55.58 | -16.53 |
|
Net Margin (%)
|
-343.85 | 9.20 | 0.67 | -195.91 | -25.83 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | -- | 0.00 |
Growth Ratios
| Research Frontiers (REFR) | Warner Music Group Corp. Class A (WMG) | Madison Square Garden Sports Corp. Class A (New) (MSGS) | Pharmhouse Corp (PHSE) | LiveOne (LVO) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-46.47 | 12.91 | 11.03 | -- | -23.12 |
|
EBIT Growth (%)
|
-28.64 | 73.23 | 791.96 | -- | -30.73 |
|
Net Profit Growth (%)
|
-28.09 | 126.26 | 134.58 | -558.18 | -4.90 |
|
EPS Growth (%)
|
-26.11 | 125.27 | 133.77 | -232.55 | -48.89 |
|
Book Value Growth (%)
|
-39.72 | 44.12 | 7.01 | 843.86 | 52.17 |
Valuation Ratios
| Research Frontiers (REFR) | Warner Music Group Corp. Class A (WMG) | Madison Square Garden Sports Corp. Class A (New) (MSGS) | Pharmhouse Corp (PHSE) | LiveOne (LVO) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-21.55 | 48.43 | -224.47 | -19.49 | -3.59 |
|
Price / Book Value
|
47.21 | 27.32 | -17.90 | 3.51 | -3.78 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
-23.98 | 19.53 | 798.66 | -20.71 | -5.34 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Research Frontiers (REFR) | Warner Music Group Corp. Class A (WMG) | Madison Square Garden Sports Corp. Class A (New) (MSGS) | Pharmhouse Corp (PHSE) | LiveOne (LVO) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.00 | 5.52 | 0.00 | 0.00 | 0.00 |
|
Short term debt to equity ratio
|
0.14 | 0.05 | -0.22 | 0.10 | -0.23 |
|
Current Ratio
|
3.54 | 0.73 | 0.50 | 0.53 | 0.64 |
|
Quick Ratio
|
3.54 | 0.72 | 0.50 | 0.51 | 0.62 |
|
Interest Coverage
|
-- | 5.99 | 1.85 | -60.18 | -3.91 |
Operating Efficiency Ratios
| Research Frontiers (REFR) | Warner Music Group Corp. Class A (WMG) | Madison Square Garden Sports Corp. Class A (New) (MSGS) | Pharmhouse Corp (PHSE) | LiveOne (LVO) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
31.79 | 31.19 | 7.65 | 3.70 | 11.43 |
|
Asset Turnover
|
0.21 | 0.50 | 0.58 | 0.23 | 1.01 |
|
Receivable days
|
173.77 | 70.66 | 21.72 | 19.75 | 34.33 |
|
Inventory Days
|
-- | 8.10 | -- | 34.86 | 7.09 |
|
Payable days
|
213.75 | 27.45 | 7.41 | 253.06 | 63.72 |
|
Cash Conversion Cycle
|
-- | 51.30 | -- | -198.45 | -22.30 |